Novel Non-Immunologic Agents for Relapsed and Refractory Multiple Myeloma: A Review Article

• Published in: Cancers Vol. 13; no. 20; p. 5210
• Main Authors: Bobin, Arthur, Gruchet, Cécile, Guidez, Stéphanie, Gardeney, Hélène, Nsiala Makunza, Laly, Vonfeld, Mathilde, Lévy, Anthony, Cailly, Laura, Sabirou, Florence, Systchenko, Thomas, Moya, Niels, Leleu, Xavier
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 18.10.2021; MDPI
• Subjects: Alkylating agents; Antigens; Bcl-2 protein; Cytotoxicity; Drug development; Drug dosages; Histone deacetylase; Immunomodulation; Immunotherapy; Mcl-1 protein; Multiple myeloma; Patients; Proteasome inhibitors; Remission (Medicine); Review; Toxicity; Transplants & implants

Novel treatments are needed to address the lack of options for patients with relapsed or refractory multiple myeloma. Even though immunotherapy-based treatments have revolutionized the field in recent years, offering new opportunities for patients, there is still no curative therapy. Thus, non-immun...